BACKGROUND: Sepsis is a life-threatening syndrome caused by a dysregulated host response to infection and remains a major global cause of mortality. Persistent immunosuppression contributes to secondary infections and adverse outcomes, yet the mechanisms underlying late-phase T-cell dysfunction remain incompletely understood. METHODS: We integrated publicly available human peripheral blood mononuclear cell single-cell RNA sequencing with a clinically relevant cecal ligation and puncture (CLP) mouse model to characterize CD8(+) T-cell states during sepsis. Key computational findings were supported by flow cytometry and RNA fluorescence in situ hybridization (RNA FISH). The immunophenotypic effects of LAG3 blockade were evaluated in septic mice. RESULTS: Single-cell analysis identified a GZMB(+)CD8(+) T-cell population with an exhaustion-like transcriptional program in sepsis, characterized by increased expression of inhibitory receptors including LAG3 and elevated ZNF683. ZNF683 expression tracked with exhaustion-associated features within the CD8(+)GZMB(+) compartment. In CLP mice, anti-LAG3 treatment partially improved frequency of GZMB(+)CD8(+) T cells by flow cytometry. RNA FISH further showed reduced ZNF683 signals in the lungs and liver of septic mice following LAG3 blockade. CONCLUSION: ZNF683 is associated with an exhaustion-like GZMB(+)CD8(+) T cell state in sepsis and may contribute to persistent T-cell dysfunction. Further mechanistic studies directly perturbing ZNF683 are needed to determine its causal role and therapeutic potential.
The transcription factor ZNF683 marks an exhaustion-like GZMB(+)CD8(+) T cell in sepsis.
转录因子 ZNF683 标志着脓毒症中类似耗竭的 GZMB(+)CD8(+) T 细胞。
阅读:4
作者:
| 期刊: | Frontiers in Immunology | 影响因子: | 5.900 |
| 时间: | 2026 | 起止号: | 2026 Mar 6; 17:1756339 |
| doi: | 10.3389/fimmu.2026.1756339 | 靶点: | CD8、GZMB |
| 研究方向: | 细胞生物学、毒理研究 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
